A drug that targets liver scarring from fatty liver disease gained Food and Drug Administration accelerated approval in March, marking the first-ever drug specifically for the disease to get the FDA’s nod. Experts hope the medication, designated a “breakthrough therapy,” proves to be a sign of more treatments to come.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Can I eat eggs, should I take supplements and what diet do you recommend I follow? Those are among the top questions Steven Simon, MD, fields most often. While he’s not a weight-loss specialist, shedding […]
The Three New Products Include Lion’s Mane, Reishi and Cordyceps Extracts, all Made with Industry-Leading Potency LAFAYETTE, Colo., April 20, 2026 /PRNewswire/ — Extract Labs, a veteran-owned wellness brand known for clean, rigorously tested products, […]
The continuing shortage of controlled stimulants, such as Adderall and Ritalin, has created a frustrating “yo-yo scenario” of providers and patients trying to find the right medications when they’re needed for attention deficit hyperactivity disorder […]
Copyright © 2026 Biotech Networks
